Comprehensive, easy-to-understand information about this condition
How we create this content →Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 7, 2026
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about HIV-associated cancer
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 4 companies have orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning HIV-associated cancer
Updated Feb 4, 2026
A case study highlights the diagnostic and therapeutic challenges of an Epstein-Barr virus (EBV)-associated smooth muscle tumor in a patient with HIV. This research underscores the complexities of managing rare tumors linked to viral infections in immunocompromised individuals.
CDC highlights effective strategies to reduce health disparities related to HIV infection rates and other health issues. The report emphasizes evidence-based interventions at both local and national levels.
A new analysis indicates that gay and bisexual men in 20 major U.S. cities who accurately know their HIV status exhibit significantly lower sexual risk behaviors. This highlights the importance of awareness and education in reducing HIV transmission.
A new policy in Malawi, known as Option B+, has led to a 700% increase in pregnant and breastfeeding women receiving antiretroviral treatment for HIV within a year. This innovative approach provides lifelong ART to all infected women, significantly impacting maternal and child health.
CDC will hold a telebriefing to discuss a new Vital Signs report focusing on HIV infections, testing, and risk behaviors among U.S. youths aged 13 to 24. The report aims to raise awareness about the impact of HIV in this demographic.